These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8287413)

  • 1. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
    Lahlou S; Duarte GP; Demenge P
    Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine-induced tachycardia in conscious rats: blunted response following isoproterenol pretreatment for 5 days.
    Lahlou S; Duarte GP
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):165-74. PubMed ID: 9777039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats.
    Lahlou S; Lima GC; Leão-Filho CS; Duarte GP
    Can J Physiol Pharmacol; 2000 Mar; 78(3):260-5. PubMed ID: 10721819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
    Lahlou S; Duarte GP
    Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted central bromocriptine-induced tachycardia in conscious, malnourished rats.
    Lahlou S; Araújo Lima PF; Interaminense LF; Duarte GP
    Pharmacol Toxicol; 2003 Apr; 92(4):189-94. PubMed ID: 12753422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
    Lahlou S
    Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of spinal dopamine D2 receptors enhances the pressor effect of intravenous quinpirole in normotensive, conscious rats.
    Lahlou S
    Pharmacol Toxicol; 2002 Feb; 90(2):94-9. PubMed ID: 12071432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model.
    Kao A; Kriett JM; Tobler HG; Detloff BL; Pritzker MR; Benson DW; Benditt DG
    J Am Coll Cardiol; 1984 Dec; 4(6):1188-94. PubMed ID: 6501720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blunted pressor responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms.
    Lahlou S
    Eur J Pharmacol; 2000 Nov; 408(1):51-62. PubMed ID: 11070183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
    Montastruc JL; Guiol C; Tran MA; Lhoste F; Montastruc P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):92-103. PubMed ID: 4062436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
    Roquebert J; Alaoui K; Morán Benito A
    J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats.
    Hamilton TC
    Br J Pharmacol; 1981 Mar; 72(3):419-25. PubMed ID: 6114765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
    Lahlou S
    Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine-induced decrease in blood pressure in conscious spontaneously hypertensive rats: evidence for a peripheral site of action.
    van den Buuse M; Lambrechts AC
    J Pharm Pharmacol; 1989 Sep; 41(9):644-6. PubMed ID: 2573712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.